# Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

> **NCT01082367** · PHASE3 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 50 (actual)

## Conditions studied

- Treatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients

## Interventions

- **DRUG:** TOBI
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01082367
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01082367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01082367, "Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01082367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*